Literature DB >> 10759761

Local challenge of oral mucosa with gliadin in patients with coeliac disease.

H Lähteenoja1, M Mäki, M Viander, A Toivanen, S Syrjänen.   

Abstract

In coeliac disease, gluten-containing diet challenges over many years are sometimes required for diagnosis, especially if the initial diagnosis was equivocal. The rectal gluten challenge has been proposed to simplify coeliac disease diagnosis. We were interested in studying whether the oral mucosa could be used for local challenge with gliadin as an aid in finalizing the diagnosis of coeliac disease. The study groups consisted of 37 treated coeliac disease patients and 10 controls. The challenges on the oral mucosa were performed either supramucosally with gliadin powder (coeliac disease patients) or by submucosal injection of dissolved gliadin (10 microg/ml) (coeliac disease patients and controls). A control challenge with submucosal gliadin solvent was made in the coeliac disease patients. B and T cells, mast cells and T cell subsets were counted and HLA-DR expression was determined. Biopsies were taken from each provoked area 24 h post-challenge. A significant increase in the number of CD4+ lymphocytes in the lamina propria (observed in 27/37 patients), but a decrease in the number of mast cells was observed in treated coeliac disease patients after submucosal challenge with gliadin. Following supramucosal challenge with gliadin the counts of intraepithelial CD4+ (in 25/37 patients) and CD8+ T cells (in 27/37 patients) increased significantly and the number of CD4+ T cells in the lamina propria was also significantly increased. Control subjects were tested by submucosal gliadin challenge and no significant changes in the number of cells were observed. HLA-DR expression did not show increased positivity in coeliac disease patients on submucosal challenge. For the first time the oral mucosa has been used for immunological testing and shown to react to gliadin challenge in coeliac disease patients. Recruitment of T cells upon submucosal gliadin challenge occurred towards the lamina propria, whereas it occurred towards the epithelium in supramucosal gliadin challenge. The numbers of T cells increased in the lamina propria after submucosal challenge. The results suggest that local oral challenge with gliadin may be used as a diagnostic method in coeliac disease; however, further studies in untreated coeliac disease patients are needed to evaluate the usefulness of this method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759761      PMCID: PMC1905618          DOI: 10.1046/j.1365-2249.2000.01177.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease.

Authors:  K Holm; M Mäki; E Savilahti; V Lipsanen; P Laippala; S Koskimies
Journal:  Lancet       Date:  1992-06-20       Impact factor: 79.321

2.  Clinical experience with suction biopsy of the rectal mucosa.

Authors:  A L FLICK; K F VOEGTLIN; C E RUBIN
Journal:  Gastroenterology       Date:  1962-06       Impact factor: 22.682

Review 3.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

Review 4.  Celiac sprue.

Authors:  J S Trier
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

5.  Studies of the rectal mucosa in coeliac sprue: the intraepithelial lymphocyte.

Authors:  L L Austin; W O Dobbins
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

6.  Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease.

Authors:  T S Halstensen; H Scott; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1989-12       Impact factor: 3.487

7.  Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.

Authors:  O Hällström
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

8.  Postpubertal gluten challenge in coeliac disease.

Authors:  M Mäki; M L Lähdeaho; O Hällström; M Viander; J K Visakorpi
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

9.  Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease.

Authors:  L K Trejdosiewicz; A Calabrese; C J Smart; D J Oakes; P D Howdle; J E Crabtree; M S Losowsky; F Lancaster; A W Boylston
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

10.  Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes.

Authors:  J Spencer; P G Isaacson; T C Diss; T T MacDonald
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

View more
  6 in total

1.  Immune response of the coeliac nasal mucosa to locally-instilled gliadin.

Authors:  P Torre; S Fusco; F Quaglia; M L La Rotonda; F Paparo; M Maglio; R Troncone; L Greco
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease?

Authors:  Na Tian; Irene Messana; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Tiziana Cabras; Alfredo D'Alessandro; Detlef Schuppan; Massimo Castagnola; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2015-04-24       Impact factor: 3.494

3.  Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis.

Authors:  Antonio Picarelli; Marco Di Tola; Raffaele Borghini; Claudia Isonne; Annarita Saponara; Mariacatia Marino; Rossella Casale; Antonio Tiberti; Roberta Pica; Giuseppe Donato; Giuseppe Frieri; Enrico Corazziari
Journal:  J Clin Immunol       Date:  2013-07-06       Impact factor: 8.317

4.  Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.

Authors:  G Kristjánsson; M Högman; P Venge; R Hällgren
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 5.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

6.  Celiac Disease Causes Epithelial Disruption and Regulatory T Cell Recruitment in the Oral Mucosa.

Authors:  Javier Sanchez-Solares; Luis Sanchez; Carmela Pablo-Torres; Celso Diaz-Fernandez; Poul Sørensen; Domingo Barber; Cristina Gomez-Casado
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.